Targeting Angiogenesis, Inflammation and Oxidative Stress in Chronic Diseases: Angiogenesis, Inflammation and Oxidative Stress in Chronic Diseases

Targeting Angiogenesis, Inflammation and Oxidative Stress in Chronic Diseases presents recent advances in the vivid molecular pathways targeting angiogenesis, inflammation, and oxidative stress that contribute very widely to the genesis of chronic diseases. The books highlights drugs from natural and synthetic origins in the management/prevention/treatment of diseases, along with the drug delivery approaches. The book’s authors from various key institutions around the globe deliver well-structured and designed chapters. The systematic presented information and knowledge will surely aid consistency and continuity. The multifaceted book is enriched with deep scientific content. Each chapter clearly defines the facts, the emerging role of molecular pathways, and targets and focus, along with key challenges and future directions that will provide new areas for researchers to explore new targets in the domain.

• Focuses on the pathogenesis of the disease, along with the molecular mechanism of action
• Includes updates on strategic design/delivery of drugs targeting angiogenesis, inflammation, and oxidative stress
• Provides recent advancements in the field of pathogenesis of chronic diseases

Professor Tapan Behl is based at Amity School of Pharmaceutical Sciences, Amity University, Sahibzada Ajit Singh Nagar, Punjab, India. Dr. Tapan Behl completed his doctoral studies from Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India and thereafter worked as Post-Doctoral Researcher. His areas of interest include diabetes and associated complications, molecular pharmacology and neuropathic pain and its complications. Dr. Behl has published more than 400 research and review papers in International and National journals. He has also published International books and is continuously engaged in exploring the molecular mechanisms in diabetes and related complications, rheumatoid arthritis and obesity.

Professor Sukhbir Singh has a PhD in Pharmaceutical Science and experience of more than 15 years in academia and research. He has 170 publications in various National/International journal of repute, 8 books, 12 books chapter and filed 19 patents to his credit. He has presented/published 40 review/research abstracts in various National/International conferences. His areas of interest in research are nanotechnology/liposome/niosomes/SEDDS based formulation development and solubility enhancement of BCS class II drugs. He has expertise in operation of various statistical analysis tools

Dr. Neelam Sharma, PhD in Pharmaceutical Science has experience of more than 13 years in academics and research. She is highly self-determined and organized pharmaceutical research professional. She has 140 publications in various National/International journal of repute, h-index 12 and i 10-index 20, 08 books, 12 books chapter and filed 19 patents to his credit. She has presented/published 35 review/research abstracts in various National/International conferences. She has completed 4 consultancy projects on herbal/homeopathic formulation. She and her team received IEDC, Govt of India, prototyping grant of Rs 2.5 lacs for project related to management of ARDS in COVID, held at Chitkara University, Punjab in 2020 and project has been completed in 2022. She has guided 1 PhD students and 20 M. Pharmacy students and 6 Ph.D students are pursuing PhD under her guidance.